BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 23532618)

  • 1. Orthovoltage radiotherapy in the management of medial canthal basal cell carcinoma.
    Krema H; Herrmann E; Albert-Green A; Payne D; Laperriere N; Chung C
    Br J Ophthalmol; 2013 Jun; 97(6):730-4. PubMed ID: 23532618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk factors for orbital exenteration in periocular Basal cell carcinoma.
    Iuliano A; Strianese D; Uccello G; Diplomatico A; Tebaldi S; Bonavolontà G
    Am J Ophthalmol; 2012 Feb; 153(2):238-241.e1. PubMed ID: 21982108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Eyelid basal cell carcinoma: non-Mohs excision, repair, and outcome.
    Hamada S; Kersey T; Thaller VT
    Br J Ophthalmol; 2005 Aug; 89(8):992-4. PubMed ID: 16024851
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Globe-sparing surgery for medial canthal Basal cell carcinoma with anterior orbital invasion.
    Madge SN; Khine AA; Thaller VT; Davis G; Malhotra R; McNab A; O'Donnell B; Selva D
    Ophthalmology; 2010 Nov; 117(11):2222-8. PubMed ID: 20570356
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single fraction radiotherapy for small superficial carcinoma of the skin.
    Chan S; Dhadda AS; Swindell R
    Clin Oncol (R Coll Radiol); 2007 May; 19(4):256-9. PubMed ID: 17379488
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Malignant eyelid tumours in Taiwan.
    Wang JK; Liao SL; Jou JR; Lai PC; Kao SC; Hou PK; Chen MS
    Eye (Lond); 2003 Mar; 17(2):216-20. PubMed ID: 12640409
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Superficial radiotherapy for patients with basal cell carcinoma: recurrence rates, histologic subtypes, and expression of p53 and Bcl-2.
    Zagrodnik B; Kempf W; Seifert B; Müller B; Burg G; Urosevic M; Dummer R
    Cancer; 2003 Dec; 98(12):2708-14. PubMed ID: 14669293
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Australian Mohs database, part II: periocular basal cell carcinoma outcome at 5-year follow-up.
    Malhotra R; Huilgol SC; Huynh NT; Selva D
    Ophthalmology; 2004 Apr; 111(4):631-6. PubMed ID: 15051193
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiotherapy for basal cell carcinoma of the medial canthus region.
    Swanson EL; Amdur RJ; Mendenhall WM; Morris CG; Kirwan JM; Flowers F
    Laryngoscope; 2009 Dec; 119(12):2366-8. PubMed ID: 19780029
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histologic safety margin in basal cell carcinoma of the eyelid: correlation with recurrence rate.
    Auw-Haedrich C; Frick S; Boehringer D; Mittelviefhaus H
    Ophthalmology; 2009 Apr; 116(4):802-6. PubMed ID: 19232734
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcomes after radiotherapy for squamous cell carcinoma of the eyelid.
    Petsuksiri J; Frank SJ; Garden AS; Ang KK; Morrison WH; Chao KS; Rosenthal DI; Schwartz DL; Ahamad A; Esmaeli B
    Cancer; 2008 Jan; 112(1):111-8. PubMed ID: 17963262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Orbital invasion by periocular basal cell carcinoma.
    Leibovitch I; McNab A; Sullivan T; Davis G; Selva D
    Ophthalmology; 2005 Apr; 112(4):717-23. PubMed ID: 15808267
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Office-based radiation therapy for cutaneous carcinoma: evaluation of 710 treatments.
    Hernández-Machin B; Borrego L; Gil-García M; Hernández BH
    Int J Dermatol; 2007 May; 46(5):453-9. PubMed ID: 17472670
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recurrent basal cell carcinoma treated with radiation therapy.
    Wilder RB; Shimm DS; Kittelson JM; Rogoff EE; Cassady JR
    Arch Dermatol; 1991 Nov; 127(11):1668-72. PubMed ID: 1952970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Retrospective analysis of local control and cosmetic outcome of 147 periorificial carcinomas of the face treated with low-dose rate interstitial brachytherapy.
    Ducassou A; David I; Filleron T; Rives M; Bonnet J; Delannes M
    Int J Radiat Oncol Biol Phys; 2011 Nov; 81(3):726-31. PubMed ID: 21435798
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The tunneled forehead flap in medial canthal and eyelid reconstruction.
    Mombaerts I; Gillis A
    Dermatol Surg; 2010 Jul; 36(7):1118-25. PubMed ID: 20653726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Basal cell carcinoma of the nose].
    Bonvallot T; Raulo Y; Zeller J; Faivre JM; Horn G; Baruch J
    Ann Dermatol Venereol; 1993; 120(3):209-14. PubMed ID: 8239358
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Radiotherapy alone for clinical T4 skin carcinoma of the head and neck with surgery reserved for salvage.
    Al-Othman MO; Mendenhall WM; Amdur RJ
    Am J Otolaryngol; 2001; 22(6):387-90. PubMed ID: 11713722
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiotherapy of periocular basal cell carcinomas: recurrence rates and treatment with special attention to the medical canthus.
    Rodriguez-Sains RS; Robins P; Smith B; Bosniak SL
    Br J Ophthalmol; 1988 Feb; 72(2):134-8. PubMed ID: 2894839
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interstitial brachytherapy of periorificial skin carcinomas of the face: a retrospective study of 97 cases.
    Rio E; Bardet E; Ferron C; Peuvrel P; Supiot S; Campion L; De Montreuil CB; Mahe MA; Dreno B
    Int J Radiat Oncol Biol Phys; 2005 Nov; 63(3):753-7. PubMed ID: 15927410
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.